CClinicalTrials.gg
RecruitingNCT05969561Updated Aug 5, 2025

Emergency Physician-performed Ultrasound-guided Femoral Nerve Blocks in Patients With Hip Fractures.

An interventional study of ultrasound-guided femoral nerve block and Intravenous or intramuscular pain medication in Hip Fractures, sponsored by National Taiwan University Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2025-08-05.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jul 2023; still recruiting 3 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Non-randomized
Ages
20 Years and older
Sex
All
01

Study summary

In this prospective study, emergency physicians perform ultrasound-guided femoral nerve block for patients with hip fractures. We compare the effectiveness of analgesia and patient satisfaction of ultrasound-guided femoral nerve block with liberal use of the pain medicine in the emergency department. The primary outcome is the assessment of time to relief the pain with fewer adverse effects and less rescue pain medication use. The secondary outcome is patient satisfaction and adverse effects for different method of pain control.

Read the detailed description

The aim of this study is to compare the effectiveness of ultrasound-guided femoral nerve blocks performed by emergency physicians for pain control in the emergency department with traditional pain medicine.

This study is a prospective before-and-after design. The enrollees are 20-year-old and older adult patients with hip fractures. We use numerical rating scale using a 0-10 scale to assess pain severity at the different time frame after giving pain medicine. The scale zero means "no pain" and scale 10 means "the worst pain imaginable".

The primary outcome is assessed by the reduction of pain scale which are taken on a numeric rating scale every 30 minutes before and after pain management. The secondary outcome compares complications, adverse effects and patient satisfaction for different method of pain control.

02

Conditions studied

  • Hip Fractures

Browse trials for

Keywords

  • Ultrasound-guided femoral nerve block
03

In context

Hip Fractures

822 studies on the registry are indexed under Hip Fractures; 160 are open to participants now.

This study's planned enrollment of 80 is below the median of 90 across 529 interventional studies indexed under Hip Fractures.

Browse Hip Fractures studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients older than 20-year-old with hip fractures
  • Stay in the emergency department for at lease two hours

Exclusion criteria

Exclusion Criteria:

  • hemodynamic unstable
  • major trauma in addition to hip fractures
  • the use of any pain management before the arrival of emergency department
  • chronic opioid use
  • inability to understood the numerical rating scale after instruction
  • allergy to local anesthetics
  • coagulopathy
  • injection site infection
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Active comparator
    Ultrasound-guided femoral nerve block

    Patients with hip fractures had underwent Ultrasound-guided femoral nerve block performed by emergency physicians.

    Procedure: ultrasound-guided femoral nerve block

  • Sham comparator
    The liberal use of pain medication

    Patients with hip fractures had given intravenous or intramuscular opioids or NSAID at the emergency department.

    Drug: Intravenous or intramuscular pain medication

Interventions

  • Procedureultrasound-guided femoral nerve block

    The local analgesia is injected and infiltrated around the femoral nerve under ultrasound guidance.

  • DrugIntravenous or intramuscular pain medication

    Intravenous or intramuscular pain medication is given for patients with hip fracture.

06

What researchers measure

Primary outcomes

  1. a short time of pain relief

    The numerical pain score from 0 to 10 is used to assess pain severity and the scale 0 means no pain and the scale 10 means the worst pain imaginable. The pain score assessed for the leg with hip fracture at rest and with movement will be recorded after different pain medicine and the reduction of pain score at different time frame will be evaluated. The more reduction of pain score, the better.

    Time frame: 2 hours

Secondary outcomes

  1. Adverse effects

    Any adverse effects of different pain medication

    Time frame: two hours

  2. Patient satisfaction

    The difference of patient satisfaction between ultrasound-guided femoral nerve block and the liberal use of pain medication

    Time frame: two hours

  3. Complications of ultrasound-guided femoral nerve block

    Any complications of ultrasound-guided femoral nerve block

    Time frame: two hours and one week after ultrasound-guided femoral nerve block or after hospital discharge

07

Study locations

1 of 1 sites recruiting
  • NTUH Yunlin Branch
    Douliu, Yunlin County 640, Taiwan
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05969561
Lead sponsor
National Taiwan University Hospital
Responsible party
Sponsor
First posted
Aug 1, 2023
Start date
Jul 3, 2023
Primary completion
Mar 5, 2025
Completion
Dec 30, 2025 (estimated)
Last update
Aug 5, 2025

Study contacts

YILIN LEE
Contact
leeatntuh@gmail.com
+886972655633

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion